Laman Utama524804 • BOM
add
Aurobindo Pharma Ltd
Tutup sebelumnya
₹1,223.95
Julat hari
₹1,221.00 - ₹1,243.00
Julat tahun
₹959.05 - ₹1,592.55
Permodalan pasaran
729.53B INR
Bilangan Purata
13.22K
Nisbah P/E
20.19
Hasil dividen
-
Pertukaran utama
NSE
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (INR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 77.96B | 7.99% |
Perbelanjaan pengendalian | 34.02B | 13.51% |
Pendapatan bersih | 8.17B | 7.95% |
Margin untung bersih | 10.48 | -0.10% |
Pendapatan bagi setiap syer | 14.00 | 9.12% |
EBITDA | 15.77B | 16.15% |
Kadar cukai berkesan | 32.34% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (INR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 68.68B | -3.93% |
Jumlah aset | 480.94B | 9.50% |
Jumlah liabiliti | 172.09B | 9.41% |
Jumlah ekuiti | 308.85B | — |
Syer tertunggak | 583.84J | — |
Harga kepada buku | 2.31 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 7.81% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (INR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 8.17B | 7.95% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer. Wikipedia
Diasaskan
1986
Ibu pejabat
Tapak web
Pekerja
26,015
